A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria
Clinical trial NCT01987947 · COMPLETED
Trial details
- NCT number
- NCT01987947
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.